Reco Biotech stock code

1. Stock code

Kerui Biotechnology (832780)

2. Company profile of Krei Biotechnology (832780)

Company name ：Hunan Kerui Biopharmaceutical Co., Ltd.

Industry: Chemical raw materials and chemical products manufacturing industry

Date of establishment: 2009-09-25

3. The main business of Kerui Biotechnology (832780)

The research and development, production and sales of steroidal biological products and plant extracts (except those requiring pre-approval) (if administrative licensing is involved, a valid license of the enterprise is required) or relevant approval documents). Extended information

Financing information

According to news on November 10, following the completion of a 500 million yuan Series A financing in early 2019, Jiangsu Ruike Biotechnology Co., Ltd. (hereinafter referred to as "Ruike Biotechnology" ”) recently completed Series B financing, with the financing amount exceeding US$100 million, including dual-currency investment in RMB and US dollars.

This round is led by well-known domestic and foreign venture capitals such as Legend Capital, Jifeng Capital, Sequoia Capital China Fund, Vertex Investment, Haitong Kaiyuan, Cornerstone Capital, Yuansheng Venture Capital, Qingsong Capital, Everbright Holdings, etc. Institutional joint investment, last round investors Dongfang Fuhai's fund, Shenzhen Woying Investment's fund, and Ningbo Haojin Grant Thornton continue to invest.

This financing will focus on the construction of the company's industrialization base for key varieties, clinical trials of HPV nine-valent vaccine, recombinant COVID-19 vaccine and other products, follow-up product pipeline research and development, core technology platform construction and international expansion, etc. Business advancement.